XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2017     47,854,510   0      
Beginning balance at Dec. 31, 2017 $ 1,020,305 $ 1,599 $ 479 $ 325,854 $ 0 $ 723,062 $ 1,599 $ (29,090)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 128,687         128,687    
Other comprehensive income, net of tax (16,889)             (16,889)
Dividends $ (82,573)         (82,573)    
Exercise of stock options (in shares) 67,898   67,898          
Exercise of stock options $ 1,540   $ 1 1,539        
Issuance of shares under Employee Stock Purchase Plan (in shares)     33,262          
Issuance of shares under Employee Stock Purchase Plan 2,084     2,084        
Vested restricted stock (in shares)     169,512          
Vested restricted stock 0   $ 2 (2)        
Repurchase and retirement of common stock (in shares)     (52,912)   (600,000)      
Repurchase and retirement of common stock (47,102)   $ (1) (3,230) $ (42,543) (1,328)    
Exchange of Series B preferred stock (in shares)     10,530          
Exchange of Series B preferred stock 0              
Share based compensation 28,093     27,965   128    
Ending balance at Dec. 31, 2018 1,035,744   $ 481 354,210 $ (42,543) 769,575   (45,979)
Ending balance (in shares) at Dec. 31, 2018     48,082,800   (600,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 218,806         218,806    
Other comprehensive income, net of tax (483)             (483)
Dividends $ (43,918)         (43,918)    
Exercise of stock options (in shares) 189,436   189,436          
Exercise of stock options $ 5,274   $ 2 5,272        
Issuance of shares under Employee Stock Purchase Plan (in shares)     66,413          
Issuance of shares under Employee Stock Purchase Plan 4,512   $ 1 4,511        
Equity portion of convertible debt 88,138     88,138        
Vested restricted stock (in shares)     185,227          
Vested restricted stock 0   $ 1 (1)        
Repurchase and retirement of common stock (in shares)     (868,947)   600,000      
Repurchase and retirement of common stock (20,803)   $ (9) (10,334) $ 42,543 (53,003)    
Share based compensation 23,922     23,856   66    
Ending balance at Dec. 31, 2019 1,311,192   $ 476 465,652 $ 0 891,526   (46,462)
Ending balance (in shares) at Dec. 31, 2019     47,654,929   0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 150,668         150,668    
Other comprehensive income, net of tax $ (8,344)             (8,344)
Exercise of stock options (in shares) 42,740   42,740          
Exercise of stock options $ 1,619     1,619        
Issuance of shares under Employee Stock Purchase Plan (in shares)     118,629          
Issuance of shares under Employee Stock Purchase Plan 7,382   $ 1 7,381        
Exercise of 3.25% Convertible Note (12)     (12)        
Vested restricted stock (in shares)     273,201          
Vested restricted stock 0   $ 3 (3)        
Repurchase and retirement of common stock (in shares)     (3,742,869)          
Repurchase and retirement of common stock (275,654)   $ (37) (42,530)   (233,087)    
Share based compensation 24,006     24,006        
Other, net 161     161        
Ending balance at Dec. 31, 2020 $ 1,211,018   $ 443 $ 456,274 $ 0 $ 809,107   $ (54,806)
Ending balance (in shares) at Dec. 31, 2020     44,346,630   0